Growth Metrics

Microbot Medical (MBOT) Cash from Financing Activities (2016)

Historic Cash from Financing Activities for Microbot Medical (MBOT) over the last 7 years, with Q4 2016 value amounting to $2.2 million.

  • Microbot Medical's Cash from Financing Activities rose 11068.69% to $2.2 million in Q4 2016 from the same period last year, while for Dec 2016 it was $8.9 million, marking a year-over-year increase of 205233.58%. This contributed to the annual value of $7.9 million for FY2024, which is 2101.25% up from last year.
  • Per Microbot Medical's latest filing, its Cash from Financing Activities stood at $2.2 million for Q4 2016, which was up 11068.69% from $154000.0 recorded in Q3 2016.
  • In the past 5 years, Microbot Medical's Cash from Financing Activities ranged from a high of $23.7 million in Q2 2015 and a low of -$20.4 million during Q4 2015
  • Moreover, its 5-year median value for Cash from Financing Activities was $2.3 million (2012), whereas its average is $4.7 million.
  • Examining YoY changes over the last 5 years, Microbot Medical's Cash from Financing Activities showed a top increase of 340188.57% in 2015 and a maximum decrease of 194854.18% in 2015.
  • Quarter analysis of 5 years shows Microbot Medical's Cash from Financing Activities stood at $5.6 million in 2012, then soared by 199.11% to $16.8 million in 2013, then tumbled by 105.94% to -$995315.0 in 2014, then plummeted by 1948.54% to -$20.4 million in 2015, then surged by 110.69% to $2.2 million in 2016.
  • Its Cash from Financing Activities was $2.2 million in Q4 2016, compared to $154000.0 in Q3 2016 and $750000.0 in Q2 2016.